Investment Sentiment Shifts to Mid Risk...High Return Bio Stocks: Samyang Biopharm and U2Bio Surg... 유진희 2026.01.15 오전 08:10 Samyang Biopharm Hits Second Straight Upper-Limit Gain [K-Bio Pulse] 김승권 2025.11.26 오전 10:44 Samyang Biopharm, T&R Biofab Surge…Peptron Volatile on Lilly Catalyst[K-Bio Pulse] 김새미 2025.12.01 오전 08:10 Paths divide for Samyang BioPharm and Epis Holdings [K-Bio Pulse] 임정요 2025.11.25 오전 08:18 Graphy Jumps on Overhang Relief, Vigencell Soars on Phase 2 Win[K-Bio Pulse] 나은경 2025.11.27 오전 08:00 로딩중..